EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single‐Cell Transcriptomic Analysis Identifies a Novel OLR1 + SLC7A7 + Liver‐Enriched Metastatic Subset With Immunometabolic Rewiring in Pancreatic Cancer

Xuan Yang, Xinyuan Chen iD, Zixin Wang, Yanfang Liu, Huiting Hu, Qingru Wu, Hailing Zhang, Yu Xiong, Xin Li, Xiaotao Cheng, Xiaoyu Ruan, Yan Gu iD

Cancer Medicine · 2025

DOI: 10.1002/cam4.71345 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Xuan Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: National key Laboratory of Immunity and Inflammation, Institute of Immunology, Naval Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Scavenger Receptors, Class A. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shuguang Program of Shanghai Education Development Foundation and Shanghai Municipal Education Commission, National Natural Science Foundation of China, Shanghai outstanding academic leaders plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pancreatic ductal adenocarcinoma (PDAC) is an exceptionally lethal malignancy, with high percents of patients presenting with liver metastases (LM). However, the mechanisms driving liver metastases remain critical bottlenecks requiring urgent exploration.

Objective

To identify the key cellular subsets driving PDAC liver metastases, elucidate their interactions with the metastatic microenvironment, and define the underlying mechanisms of liver colonization. Materials and Methods Integrated single‐cell transcriptomic analysis was performed using scRNA‐seq data of PT and LM. The expression of signature genes within the identified cell subset was validated using clinical samples from PDAC PT and LM patients. Furthermore, ligand‐receptor network analysis was conducted between the specific tumor cell subset and key immune cells.

Results

We identified a novel liver‐enriched metastatic subset (LEMS), a terminally differentiated malignant cell subpopulation characterized by metabolic reprogramming and hyperactivation of immunosuppressive pathways. We further validated the LEMS signature genes, oxidized low‐density lipoprotein receptor 1 (OLR1) and solute carrier family 7 member 7 (SLC7A7), as potential diagnostic biomarkers for liver metastases. Importantly, we found that SPP1 + macrophages interacted with LEMS via ligand‐receptor networks, thereby driving invasion and immune evasion.

Discussion

We revealed the highly malignant features of LEMS and crosstalk between LEMS and SPP1 + macrophages in liver metastases. However, it is necessary to expand clinical cohorts and in vivo models to comprehensively elucidate the specific mechanistic interactions between LEMS and macrophages.

Conclusion

We delineated LEMS as an enriched subset in LM and proposed targeting of LEMS‐SPP1 + macrophage interactions as a therapeutic strategy to disrupt metastatic progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsPancreatic NeoplasmsCarcinoma, Pancreatic DuctalScavenger Receptors, Class AHumansSingle-Cell AnalysisGene Expression ProfilingTumor MicroenvironmentAnimalsGene Expression Regulation, NeoplasticBiomarkers, TumorTranscriptomeMacrophagesMice

Stichwörter der Autor:innen

immunosuppressionliver metastasesmacrophagesmetabolic reprogrammingpancreatic ductal adenocarcinoma

Substanzen

Scavenger Receptors, Class ABiomarkers, Tumor

Autor:innen und Institutionen

  • National key Laboratory of Immunity and Inflammation, Institute of Immunology, Naval Medical University, Shanghai, China.
  • Department of Pathology, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Department of Neurology, Changhai Hospital, Naval Medical University, Shanghai, China.
  • AisenseBio Biomedical Technology Co., Ltd., JiangSu, China.

ORCID-Profile: Xinyuan Chen, Yan Gu

Förderung

  • Shuguang Program of Shanghai Education Development Foundation and Shanghai Municipal Education Commission
  • National Natural Science Foundation of China
  • Shanghai outstanding academic leaders plan

Zitieren

APA

Yang, X., Chen, X., Wang, Z., Liu, Y., Hu, H., Wu, Q., Zhang, H., Xiong, Y., Li, X., Cheng, X., Ruan, X., & Gu, Y. (2025). Single‐Cell Transcriptomic Analysis Identifies a Novel OLR1 + SLC7A7 + Liver‐Enriched Metastatic Subset With Immunometabolic Rewiring in Pancreatic Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.71345

Vancouver

Yang X, Chen X, Wang Z, Liu Y, Hu H, Wu Q, et al. Single‐Cell Transcriptomic Analysis Identifies a Novel OLR1 + SLC7A7 + Liver‐Enriched Metastatic Subset With Immunometabolic Rewiring in Pancreatic Cancer. Cancer Medicine. 2025. doi:10.1002/cam4.71345

BibTeX
@article{Yang2025,
  author = {Yang, Xuan and Chen, Xinyuan and Wang, Zixin and Liu, Yanfang and Hu, Huiting and Wu, Qingru and Zhang, Hailing and Xiong, Yu and Li, Xin and Cheng, Xiaotao and Ruan, Xiaoyu and Gu, Yan},
  title = {Single‐Cell Transcriptomic Analysis Identifies a Novel OLR1 + SLC7A7 + Liver‐Enriched Metastatic Subset With Immunometabolic Rewiring in Pancreatic Cancer},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.71345}
}
Kostenlos starten →